MagicMed Industries CEO Dr Joseph Tucker joined Steve Darling from Proactive to bring news the company just closed their first financial raise bringing in 1.6 million which was oversubscribed due to demand.
Tucker talks about the success of the raise and where that money is going to be used, including some new hires. Tucker also addressed a recent decision in Canada to allow Psilocybins to be used by 4 terminally ill patients.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of MagicMed Industries Inc named herein, including the promotion by the Company of MagicMed Industries Inc in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
MagicMed Industries CEO Dr. Joseph Tucker joined Steve Darling from Proactive with news the company completed the development of their psilocybin-derivatives patent portfolio which they call “The Psybrary” Tucker says the Psybrary is a collection of novel psychedelic-derivative drug...
Prev article
